kr445 - That's What Analysts Think Bonesupport Holding AB (publ) (STO:BONEX) Is Worth After These Results

Shareholders of Bonesupport Holding AB (publ) (STO:BONEX) will be pleased this week, given that the stock price is up 14% to kr386 following its latest yearly results. The result was positive overall - although revenues of kr899m were in line with what the analysts predicted, Bonesupport Holding surprised by delivering a statutory profit of kr2.01 per share, modestly greater than expected. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.

Check out our latest analysis for Bonesupport Holding

Following the latest results, Bonesupport Holding's three analysts are now forecasting revenues of kr1.32b in 2025. This would be a substantial 47% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to shoot up 156% to kr5.20. In the lead-up to this report, the analysts had been modelling revenues of kr1.34b and earnings per share (EPS) of kr4.67 in 2025. Although the revenue estimates have not really changed, we can see there's been a decent improvement in earnings per share expectations, suggesting that the analysts have become more bullish after the latest result.

The analysts have been lifting their price targets on the back of the earnings upgrade, with the consensus price target rising 5.4% to kr445. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. The most optimistic Bonesupport Holding analyst has a price target of kr486 per share, while the most pessimistic values it at kr400. Still, with such a tight range of estimates, it suggeststhe analysts have a pretty good idea of what they think the company is worth.

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Bonesupport Holding's past performance and to peers in the same industry. It's clear from the latest estimates that Bonesupport Holding's rate of growth is expected to accelerate meaningfully, with the forecast 47% annualised revenue growth to the end of 2025 noticeably faster than its historical growth of 38% p.a. over the past five years. Compare this with other companies in the same industry, which are forecast to grow their revenue 19% annually. Factoring in the forecast acceleration in revenue, it's pretty clear that Bonesupport Holding is expected to grow much faster than its industry.

The Bottom Line

The most important thing here is that the analysts upgraded their earnings per share estimates, suggesting that there has been a clear increase in optimism towards Bonesupport Holding following these results. Happily, there were no major changes to revenue forecasts, with the business still expected to grow faster than the wider industry. We note an upgrade to the price target, suggesting that the analysts believes the intrinsic value of the business is likely to improve over time.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. At Simply Wall St, we have a full range of analyst estimates for Bonesupport Holding going out to 2027, and you can see them free on our platform here..

You still need to take note of risks, for example - Bonesupport Holding has 1 warning sign we think you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.